华昊中天医药-B

02563
3.4000.29% ( -0.010 )
延迟 已收盘: 11月20日 16:08:00

股东

全部股东

股东类型

  • 私营企业44.90%
  • 公众及其他19.99%
  • 风投/私募13.84%
  • 机构投资者8.90%
  • 其他12.37%

主要股东

主要股东 最新
股东
Baygen QT Inc
10.40%4,050.59 万0.71%+0
Shanghai Xin Sheng De Yuan Enterprise Management Centre (Limited Partnership)
8.93%3,479.83 万--+3,479.83 万
Tibet Xinsheng Deyuan Venture Capital Management Co., Ltd
8.93%3,479.83 万0.61%+0
SDIC (Shanghai) Venture Capital Management Co., Ltd.
7.55%2,942.67 万0.52%+0
Baiyang Pharmaceutical Group Co., Ltd.
7.49%2,917.08 万--+2,917.08 万
Li TangCo-Founder, Chairperson, Chief Scientific Officer & Chief Marketing Officer
7.44%2,898.65 万0.51%+0
Tibet Renhe Zhengtai Venture Capital Management Co., Ltd.
6.28%2,447.59 万0.43%+0
Shenzhen Efung Investment Management Limited Partnership Enterprise
5.60%2,182.73 万0.38%+0
Beijing Biostar Pharmaceuticals Co., Ltd, ESOP
4.93%1,922.09 万0.34%+0
Zhuhai Huajin Haoyuan Enterprise Management Partnership (Limited Partnership)
4.93%1,922.09 万0.34%+0
Zhuhai Huaxin Haoyuan Business Management Partnership (Limited Partnership)
3.59%1,400.20 万0.25%+0
Fortune Venture Capital Co., Ltd.
3.29%1,282.22 万0.23%+0
Zhuhai Huarong Haoyuan Enterprise Management Partnership (Limited Partnership)
0.51%200.03 万0.04%+0
Beijing Baygen Technologies Ltd.
0.11%41.96 万<0.01%+0
China Universal Asset Management Company Ltd.
<0.01%3.73 万<0.01%+0